West Lafayette, IN, United States of America

Curtis L Ashendel

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Purdue Research Foundation, Industrial Technology Research Institute, International Technology Research Institute. Active years: 1996-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Curtis L Ashendel. Retrieved from https://idiyas.com/inventor/curtis-l-ashendel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1996-2005

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Curtis L. Ashendel: Innovator in Anti-Tumor Agents

Introduction

Curtis L. Ashendel is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of anti-tumor agents, holding a total of 4 patents. His work focuses on novel compounds that have the potential to combat cancer effectively.

Latest Patents

Among his latest patents, Ashendel has developed selenophene anti-tumor agents. These patents describe novel selenophene compounds that are useful as anti-tumor agents. The preferred compounds include those of a specific formula that showcases their potential efficacy in cancer treatment.

Career Highlights

Throughout his career, Ashendel has been associated with reputable organizations such as the Purdue Research Foundation and the International Technology Research Institute. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ashendel has collaborated with notable colleagues, including Ching-jer Chang and Darrick Kim. These partnerships have enriched his research endeavors and fostered innovation in the field of anti-tumor agents.

Conclusion

Curtis L. Ashendel's contributions to the development of anti-tumor agents highlight his innovative spirit and dedication to cancer research. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…